<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Protox Therapeutics Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Protox Therapeutics Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Protox_Therapeutics_Inc-3044820</link>
<lastBuildDate>Saturday, October 11, 2008 8:18:15 AM</lastBuildDate>
<alacra:xlsid>3044820</alacra:xlsid>
<alacra:company>Protox Therapeutics Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0001-27312511</link><guid isPermaLink="false">newstex/PRN-0001-27312511</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (Canada NewsWire Group delivered by Newstex) -- VANCOUVER, Aug. ## /CNW/ -- Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today released second quarter #### financial...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04009002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001004</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><pubDate>8/11/2008 8:19:44 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Canada NewsWire Group</newstex:Publication><title>Protox reports 2008 second quarter results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0001-27312511</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">PROTOX THERAPEUTICS INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PRX</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PTXRF</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item></channel></rss>